The 2019 outlook for health insurers in the United States looks stable; Senator Bernie Sanders, I-Vermont, and Representative Ro Khanna, D-California, have released a bill that takes cues from President Donald Trump’s proposal to reduce Medicare drug costs through the use of an international pricing index; older Americans should be aware of what is in their medical records and whether the data are accurate.
Moody’s Investor Services has announced that the 2019 outlook for health insurers in the United States looks stable. According to the credit ratings agency, the stable outlook can be attributed to things like insurers adjusting to the Affordable Care Act and achieving profits in these marketplace plans. While Moody’s expects vertical integration will continue in 2019, it expects these efforts to continue on a smaller scale.
Senator Bernie Sanders, I-Vermont, and Representative Ro Khanna, D-California, have released a bill that takes cues from President Donald Trump’s proposal to reduce Medicare drug costs through the use of an international pricing index. Politico reported that the bill would also tie US drug costs to international prices, although Trump’s proposal is narrower and only applies to Medicare Part B. Under Sanders and Khanna’s bill, drug companies would be incentivized to charge prices similar to those in other countries, and if they do not, the government could intervene to allow generic competition.
Older Americans should be aware of what is in their medical records and whether the data are accurate. It is estimated that nearly 10% of people who access their records online end up requesting corrections to it. Kaiser Health News dived into the accuracy of medical records and the difficulties that can occur if an incorrect diagnosis or test result ends up in a record, which can result in inappropriate treatment. However, additions aren’t the only concern—omissions from records can also wreak havoc.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen